date:Jan 22, 2013
April 1. Riisgard has presided over the organisation for twelve years. Holk Neilsen was previously executive vice president and head of the Enzyme Business, a position he has held since 2007.
We delivered strong earnings growth and record profitability in a year when organic sales growth was challenged and came in at 4% below our ambition, said Riisgaard With 2012 behind us, we have reviewed our long-term growth scenarios and decided to adjust our long-term financial targets. We are still con